PROFFERED PAPERS 4 - SCLC AND LOCALLY ADVANCED NSCLC

Cabazitaxel (cbz) vs topotecan (tpt) in patients (pts) with small cell lung cancer (SCLC) with progressive disease during/after first-line (1l) treatment with platinum-based chemotherapy (ctx)

T. Evans